Funding Received
$44.5 Million in 3 Rounds from 4 Investors
Most Recent Funding
$17.4 Million Series C on August 31, 2009
Headquarters:
Cambridge, MA
Description:
Pervasis Therapeutics is a clinical stage company offering a broad portfolio of biologically active therapeutics.
Founders:
Robert S. Langer
Categories:
Biotechnology
Website:
http://www.pervasistx.com

Company Details

Update

Pervasis Therapeutics is a clinical stage company developing a broad portfolio of biologically active therapeutics. Building on its deep understanding of the specialized role that the endothelium plays in regulating natural healing and repair processes associated with disease, Pervasis is advancing groundbreaking new therapies to dramatically improve the outcomes of common vascular interventions, such as arteriovenous access, angioplasties, stents, and peripheral and coronary bypass grafts – the failure of which result in serious complications and a significant increase in medical costs.

Past Team (2)

Update

Board Members and Advisors (2)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    One Kendall Square, Ste. B6101

    Cambridge, MA 02139

    USA

Images (1)

Update
  • 632fbf185350e649ced6b3b2fe71cd0f